20200 West Dixie Hwy, Suite 808D, Miami, FL 33180
|
No Insurance Accepted
Clinical Evidence & Treatment Duration

How Long Does the O-Shot® Last?
What Research Actually Shows

Medically reviewed by Nina Gupta, MD, ABAARM, FAARM • O-Shot® Miami | Miami, Florida

November 17, 2026 • Dr. Nina Gupta, MD
How Long Does the O-Shot® Last - Evidence and Clinical Trial Review by Dr. Nina Gupta in Miami

Quick Summary: How Long Do Results Last?

The Short Answer: There is no scientifically established average duration for O-Shot® results. Although some commercial clinics advertise benefits lasting 12 to 18 months, available controlled studies do not establish this as a reliable treatment timeline. Individual experiences vary considerably, and the clinical evidence remains preliminary. Understanding these scientific limitations helps you make an informed decision grounded in diagnosis rather than marketing claims.

One of the most common questions women ask when exploring the O-Shot® is surprisingly simple:

“How long will the results last?”

It is an understandable question. Whether you are experiencing changes after childbirth, discomfort during menopause, or concerns about intimate sensation, you want to know what to expect before considering a medical procedure.

You may have seen websites suggesting that O-Shot® results last 12 to 18 months. Some clinics even routinely recommend yearly maintenance treatments. But what does medical research actually tell us?

The answer is more complicated than many advertisements suggest.

The O-Shot® uses platelet-rich plasma (PRP), a substance prepared from your own blood. Researchers are actively investigating whether PRP injections may influence certain aspects of female sexual function. However, the evidence remains preliminary.

There is currently insufficient high-quality research to establish how long O-Shot® benefits last, whether every patient will experience improvement, or whether repeat treatments provide additional benefit. Understanding these limitations can help you make a more informed decision about your intimate health.


What Is the O-Shot®?

The O-Shot® is a medical procedure involving injections of platelet-rich plasma into selected intimate tissues, including the anterior vaginal wall and peri-clitoral area.

PRP is prepared by collecting a small blood sample from your arm and processing it in a specialized centrifuge to separate and concentrate the platelets from red blood cells.

Platelets contain proteins and biological growth factors that are naturally involved in normal wound healing and tissue repair. Researchers are interested in whether these concentrated biological components may influence local tissue responses when introduced into pelvic structures.

Growth Factors vs. Clinical Outcomes

The presence of concentrated growth factors in a laboratory test tube does not automatically mean that PRP injections produce meaningful clinical improvements in live human patients. The effectiveness of PRP depends on several critical factors, including the specific medical condition being treated, preparation technique, platelet concentration, injection location, and treatment protocol.

PRP has been studied in multiple medical specialties—such as orthopedics, sports medicine, and dermatology—but findings from one clinical application cannot automatically be applied to female intimate tissues.

For female intimate wellness, important clinical questions remain unanswered. These include whether PRP produces consistent benefits, which specific patients are most likely to respond, and how long any observed improvement might last.


How Long Does the O-Shot® Typically Last?

The Short Answer

There is no scientifically established average duration for O-Shot® results. Although some clinics advertise benefits lasting 12 to 18 months, available controlled studies do not establish this as a reliable or predictable treatment timeline.

Individual experiences may differ considerably. Some women report noticeable improvement after treatment, while others may notice little or no change at all.

Why Patient Testimonials Can Be Misleading

Patient testimonials can provide insight into personal experiences, but they cannot scientifically establish how frequently a treatment works or how long its effects last.

Why? Because female intimate symptoms fluctuate naturally over time.

Hormonal changes, prescription medications, relationship dynamics, emotional stress, fatigue, sleep quality, and underlying medical health all influence intimate wellness from month to month. Without carefully designed controlled studies, it is impossible to determine whether reported improvements resulted from the biological action of PRP itself or from other life influences.

This is precisely why medical researchers rely on blinded, randomized clinical trials.


What Does the Latest Research Say? The 2026 Clinical Trial

A randomized controlled trial published in Obstetrics & Gynecology in May 2026 examined PRP injections and female sexual function under rigorous conditions.

Study Summary: Clarke et al. (Obstetrics & Gynecology, May 2026)

  • Participants: 52 sexually active premenopausal women between 18 and 50 years old without severe sexual dysfunction.
  • Intervention: Participants received either autologous PRP injections or an inactive saline placebo injection.
  • Evaluation: Changes were measured using the Female Sexual Function Index (FSFI), a standardized clinical questionnaire, at six weeks and six months.
  • Key Outcome: The PRP group demonstrated greater improvement in composite FSFI scores at six weeks and six months. However, differences in individual subdomains—including desire, arousal, lubrication, and orgasm—were not statistically significant compared with the placebo group.

While this controlled trial offered encouraging findings for overall subjective scores, several important scientific limitations must be emphasized:

  • Small Sample Size: The trial involved only 52 participants, which limits the statistical power to detect small differences.
  • Premenopausal Population Only: All participants were premenopausal women under 50. The study did not include menopausal or postmenopausal women.
  • Six-Month Follow-Up: The study followed participants for six months. Therefore, it cannot establish that O-Shot® results last 12 to 18 months.
  • Narrow Scope: The trial cannot establish effectiveness for menopausal vaginal dryness, urinary leakage, or women suffering from severe sexual dysfunction.

Larger multicenter studies involving diverse patient populations and multi-year follow-up periods are necessary before reliable timelines can be verified.

Formal Reference: Clarke B, et al. Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A Randomized Controlled Trial. Obstetrics & Gynecology. 2026;147(5):627–635.

Does the O-Shot® Work for Every Woman?

No medical treatment works equally well for everyone.

With the O-Shot®, researchers have not yet identified reliable clinical characteristics or biomarkers that predict which women will experience a benefit.

Age, menopausal status, complete medical history, and the underlying root cause of symptoms are all critical to a woman's health. However, there is insufficient evidence to establish that these factors reliably predict PRP treatment success or duration.

For example, a woman experiencing intimacy discomfort because of menopause-related estrogen depletion requires a completely different therapeutic approach from someone experiencing pelvic floor muscle hypertonicity or spasm.

Similarly, low sexual desire is frequently influenced by prescription medications (such as SSRI antidepressants or hormonal birth control), emotional health, relationship dynamics, chronic stress, or sleep disturbances.

A single injection procedure cannot address every possible cause of intimate changes. This is why an individualized medical evaluation by a licensed physician is essential before choosing any therapy.


Can Menopause Affect O-Shot® Results?

Menopause causes profound, progressive changes in systemic estrogen levels. Declining estrogen directly affects the tissues of the vagina, vulva, urethra, and bladder base.

Many women notice persistent dryness, tissue thinning, burning, irritation, painful intimacy (dyspareunia), or urinary symptoms. Clinically, this constellation of changes is recognized as Genitourinary Syndrome of Menopause (GSM).

GSM is a well-understood medical condition with established, guideline-supported treatment options:

Guideline-Supported First-Line GSM Care

  • 2025 AUA Guidelines: The 2025 American Urological Association (AUA) guidelines strongly recommend offering local low-dose vaginal estrogen (creams, tablets, or rings) to appropriate patients experiencing GSM-related dryness and discomfort.
  • Non-Hormonal Moisturizers & Lubricants: Long-acting hyaluronic acid moisturizers and silicone lubricants provide immediate, non-invasive tissue comfort.
  • Prescription Alternatives: Vaginal DHEA (prasterone) suppositories and oral ospemifene are FDA-approved medical alternatives for dyspareunia.

PRP injections have not been established as a replacement for these proven treatments.

Importantly, there is insufficient evidence to conclude that menopause makes O-Shot® results shorter-lasting, or that combining PRP with hormone therapy improves treatment durability. A physician should evaluate menopausal symptoms thoroughly before recommending any elective procedure.


What About Urinary Leakage?

Many women who research the O-Shot® are troubled by involuntary urinary leakage.

Leakage that occurs during physical exertion—such as coughing, sneezing, laughing, exercising, or lifting something heavy—typically indicates stress urinary incontinence (SUI). Other women experience sudden, uncontrollable urinary urgency or frequent bathroom trips, which may point toward overactive bladder (urge incontinence).

These conditions have different anatomical mechanisms and require distinct treatment pathways:

Stress Incontinence (SUI)

Supervised pelvic floor physical therapy and muscle training (PFMT with biofeedback) represent the established, conservative first-line standard of care.

Overactive Bladder (OAB)

Guideline-backed care includes structured bladder training, behavioral fluid modifications, pelvic floor therapy, and targeted anticholinergic or beta-3 agonist medications.

The O-Shot® has not been established as an effective treatment for urinary incontinence.

Although PRP is currently being investigated, there is insufficient evidence to recommend routine PRP injections for bladder control. Women experiencing persistent urinary leakage should seek a comprehensive medical diagnosis rather than assuming that an injection will correct the underlying problem.


When Should You Expect O-Shot® Results?

You may encounter commercial marketing claims stating that O-Shot® improvements begin within a few weeks and reach their peak effect after several months.

However, a predictable or guaranteed timeline has not been established in medical literature.

In the 2026 randomized controlled trial, researchers measured outcomes at six weeks and six months. Those specific research assessment points should not be misinterpreted as a promised schedule of clinical improvement.

Some women report subjective changes after treatment, while others experience no meaningful benefit.

Furthermore, there is insufficient evidence to conclude that collagen production, nerve regeneration, or increased blood flow consistently explains reported changes in intimate wellness symptoms. These biological mechanisms remain active areas of scientific investigation. Patients should never be promised a specific onset, peak response, or duration of benefit.


Is the O-Shot® Permanent?

No scientific evidence establishes the O-Shot® as a permanent treatment for female sexual function concerns, bladder leakage, or menopausal discomfort.

However, it is equally inaccurate to suggest that all patients experience a predictable period of improvement followed by gradual fading. That clinical pattern has not been reliably demonstrated across controlled studies.

Some symptoms may improve, worsen, or fluctuate over time for reasons completely unrelated to PRP.

If symptoms return or evolve, the appropriate next step is a comprehensive medical reassessment. A return of vaginal dryness or urinary leakage does not necessarily mean that an injection has worn off; it may indicate progressive hormonal changes, pelvic floor muscle tension, a localized infection, medication side effects, or another condition requiring targeted medical care.


How Often Should You Repeat the O-Shot®?

Some commercial providers suggest repeating PRP injections annually, while others recommend repeat sessions after only a few months.

However, there is no established, evidence-based maintenance schedule for the O-Shot®.

Researchers have not determined whether repeat injections consistently improve outcomes, how many procedures are safe or appropriate, or whether repeated treatments provide lasting benefit. The long-term safety of repeated PRP injections into pelvic tissues also requires further scientific study.

Before considering another procedure, patients should discuss whether their original symptoms showed clinically meaningful improvement and whether established medical alternatives may be more appropriate. Repeat treatment should never be presented as automatically necessary.


Is the O-Shot® Safe?

Because PRP is prepared from a patient's own blood, some people assume the procedure is completely risk-free.

That assumption is medically incorrect.

Although utilizing autologous blood eliminates the risk of allergic rejection or foreign-body reactions, the mechanical injection itself carries potential risks.

Localized pain and soreness

Bruising, bleeding, and hematoma

Bacterial infection risk

Transient nerve irritation or dysuria

Individual medical conditions and medications (such as blood thinners or anti-inflammatories) also affect procedural suitability.

While the 2026 randomized trial reported no serious adverse events, a small study of 52 participants cannot reliably detect uncommon complications or evaluate long-term tissue safety.

Regulatory Status Note

The O-Shot® procedure is not FDA-approved for treating female sexual dysfunction, urinary incontinence, or menopausal symptoms. FDA 510(k) clearance of certain centrifuge preparation devices establishes only that the device safely separates blood components—it does not establish FDA approval of the clinical procedure for intimate wellness.


What Treatments Have Stronger Supporting Evidence?

The most effective treatment depends entirely on an accurate underlying diagnosis. When intimate concerns arise, proven, guideline-backed treatments should be reviewed first:

For Menopausal Dryness & GSM

Established options include non-hormonal vaginal moisturizers, prescription local low-dose estrogen (creams, tablets, rings), vaginal DHEA, and oral ospemifene.

For Pelvic Floor Dysfunction

Specialized pelvic floor physical therapy with a licensed therapist to retrain weak or hypertonic pelvic floor muscles.

For Urinary Urgency

Bladder retraining, fluid management, pelvic floor coordination, and guideline-supported medical therapies.

For Sexual Desire & Arousal

Comprehensive evaluation of endocrine markers, medication side effects, psychological stressors, relationship health, and sex therapy.

The clinical goal should never be to find a single procedure that promises to solve everything. Instead, the goal is to understand the root cause of symptoms and select treatments supported by robust clinical evidence.


What Happens During an O-Shot® Consultation in Miami?

At O-Shot® Miami, Dr. Nina Gupta, MD, ABAARM, FAARM, provides unhurried, individualized consultations for women seeking clarity about their intimate wellness.

Your private consultation includes a thorough review of your current symptoms, medical history, medications, menopausal status, and any previous treatments. Depending on your health concerns, further diagnostic testing or referral to a specialist may be recommended.

Women interested in PRP therapy can discuss available clinical trials, potential risks, its investigational status, and established alternatives in an open, judgment-free environment.

A consultation does not mean that PRP treatment will necessarily be recommended. The most appropriate care plan depends entirely on your personal medical needs.


Frequently Asked Questions About O-Shot® Results

There is no scientifically established average duration. Claims of 12–18 months have not been adequately confirmed through high-quality, long-term controlled studies. Responses vary widely between individuals, and long-term durability remains uncertain.

A reliable timeline has not been established. Research has evaluated outcomes at specific follow-up intervals (such as six weeks and six months), but these do not guarantee when or whether an individual will notice improvement.

PRP is being investigated for intimate wellness concerns, but effectiveness for menopause-related symptoms remains unproven. Established Genitourinary Syndrome of Menopause (GSM) treatments—such as local vaginal estrogen—have significantly stronger supporting clinical evidence.

There is insufficient evidence to establish PRP injections as an effective treatment for urinary incontinence. Pelvic floor physical therapy and other established treatments should be considered according to the specific diagnosis.

No. The O-Shot® procedure is not FDA-approved for female sexual dysfunction, urinary incontinence, or menopausal symptoms. FDA clearance of certain centrifuge preparation devices does not establish FDA approval of the clinical procedure for intimate wellness.

There is no established maintenance schedule. The benefits and long-term safety of repeated injections require further research. Repeat treatment should not be presented as automatically necessary.

A medical reassessment can help identify other possible causes of symptoms. Established treatments may include pelvic floor physical therapy, appropriate hormonal or nonhormonal therapies, and condition-specific medical care.

Final Thoughts: Understanding O-Shot® Results

The question “How long does the O-Shot® last?” deserves an evidence-based answer.

Current research does not establish a predictable duration of benefit. Although preliminary studies have reported some encouraging findings, larger trials are needed to determine effectiveness, safety, appropriate patient selection, and long-term outcomes.

For women experiencing changes in intimate wellness, menopause-related discomfort, or urinary concerns, an individualized medical evaluation is an important first step.

At O-Shot® Miami, Dr. Nina Gupta, MD, helps women understand their symptoms, current treatment evidence, and available medical options. To learn more, schedule a confidential consultation at O-Shot® Miami.

Medical disclaimer: This article is for educational purposes and does not replace individualized medical advice. PRP injections for female intimate wellness remain investigational. Results are not guaranteed, and treatment decisions should be made with a qualified healthcare professional.

Private Physician Consultation

Discuss your intimate wellness symptoms, health history, and evidence-based treatment options with Dr. Nina Gupta, MD.

Book Consultation
Dr. Nina Gupta, MD - Miami Sexual Wellness Specialist

Dr. Nina Gupta, MD

With over 37 years of clinical medical experience, Dr. Nina Gupta (ABAARM, FAARM) specializes in women's intimate wellness, regenerative therapies, and personalized longevity care in Miami.

REQUEST A COMPLIMENTARY CALL-BACK

Have a Question About a
Treatment?

Request a complimentary call-back from Dr. Nina Gupta's team. We'll answer your preliminary questions and help you understand our treatment options at no cost.

Medical Appointments & Fees: While phone inquiries are complimentary, clinical evaluations carry a fee. The O-Shot® treatment package is $1,500 (includes Labia Wing Lift when appropriate); the comprehensive initial hormone optimization consultation with diagnostic bloodwork is $750.

Please do not submit confidential medical records or sensitive health details through this website form. By submitting, you acknowledge our Privacy Policy.